← Back to headlines
US FDA Approves Breakthrough Pancreatic Cancer Drug Showing Improved Survival Rates
The US Food and Drug Administration has granted approval to a novel pancreatic cancer therapy that clinical trials show significantly extends patient survival. The landmark decision marks a major advancement in treating one of the most aggressive forms of the disease.
27 Aug, 01:45 — 27 Aug, 06:54
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (46/100)3 sources25/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
NPR
Center2
Center (2)
balkan-webmyjoyonline
Right
Far R
Geographic diversity— 3 regions13/34
US1Albania1Ghana1
Sources
Showing 2 of 3 sources
NPRHigh32m ago
FDA approves landmark pancreatic cancer drug that's shown to improve survival
U.S. health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly form of cancer, by blocking a protein that fuels tumor growth in the vast majority of cases.
By The Associated Press
Read full article →myjoyonlineMixed5h ago
US drug agency approves breakthrough treatment for pancreatic cancer
The US Food and Drug Administration has approved a treatment for pancreatic cancer that, in clinical trials, nearly doubled the overall survival time for patients.
By Abubakar Ibrahim
Read full article →Coverage Timeline
First report: myjoyonline · 27 Aug, 01:45|Full coverage: 3 · 5h|Window: 5h
Left-leaningCenterRight-leaning
